129 related articles for article (PubMed ID: 27287205)
1. Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcome.
Ruiz-Pinto S; Pita G; Patiño-García A; García-Miguel P; Alonso J; Pérez-Martínez A; Sastre A; Gómez-Mariano G; Lissat A; Scotlandi K; Serra M; Ladenstein R; Lapouble E; Pierron G; Kontny U; Picci P; Kovar H; Delattre O; González-Neira A
Ann Oncol; 2016 Sep; 27(9):1788-93. PubMed ID: 27287205
[TBL] [Abstract][Full Text] [Related]
2. Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study.
Caronia D; Patiño-Garcia A; Peréz-Martínez A; Pita G; Moreno LT; Zalacain-Díez M; Molina B; Colmenero I; Sierrasesúmaga L; Benítez J; Gonzalez-Neira A
PLoS One; 2011; 6(10):e26091. PubMed ID: 22016816
[TBL] [Abstract][Full Text] [Related]
3. Effect of variation of ABCB1 and ABCC3 genotypes on the survival of bone tumor cases after chemotherapy.
Yang J; Wang ZG; Cai HQ; Li YC; Xu YL
Asian Pac J Cancer Prev; 2013; 14(8):4595-8. PubMed ID: 24083708
[TBL] [Abstract][Full Text] [Related]
4. Factors Influencing Mortality in Children with Central Nervous System Tumors: A Cohort Study on Clinical Characteristics and Genetic Markers.
Torres-Espíndola LM; Pérez-De Marcos JC; Castillejos-López M; Velasco-Hidalgo L; Cárdenas-Cardós R; De Uña-Flores A; Salinas-Lara C; Caballero-Salazar S; Fernández-Plata R; Aquíno-Gálvez A
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674407
[TBL] [Abstract][Full Text] [Related]
5. Predictive potential of ABCB1, ABCC3, and GSTP1 gene polymorphisms on osteosarcoma survival after chemotherapy.
Liu S; Yi Z; Ling M; Shi J; Qiu Y; Yang S
Tumour Biol; 2014 Oct; 35(10):9897-904. PubMed ID: 24996541
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial.
Ruiz-Pinto S; Martin M; Pita G; Caronia D; de la Torre-Montero JC; Moreno LT; Moreno F; García-Sáenz JÁ; Benítez J; González-Neira A
Pharmacogenet Genomics; 2018 Nov; 28(11):245-250. PubMed ID: 30334909
[TBL] [Abstract][Full Text] [Related]
7. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy.
Ufer M; Mosyagin I; Muhle H; Jacobsen T; Haenisch S; Häsler R; Faltraco F; Remmler C; von Spiczak S; Kroemer HK; Runge U; Boor R; Stephani U; Cascorbi I
Pharmacogenet Genomics; 2009 May; 19(5):353-62. PubMed ID: 19415824
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.
Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182
[TBL] [Abstract][Full Text] [Related]
9. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
[TBL] [Abstract][Full Text] [Related]
10. Interaction of arsenic trioxide and etoposide in Ewing sarcoma cell lines.
Lenz JE; Riester R; Schleicher SB; Handgretinger R; Boehme KA; Traub F
Oncol Rep; 2020 Jan; 43(1):337-345. PubMed ID: 31746397
[TBL] [Abstract][Full Text] [Related]
11. Unusual sites of Ewing sarcoma (ES): a retrospective multicenter 30-year experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP) and Italian Sarcoma Group (ISG).
Berger M; Fagioli F; Abate M; Riccardi R; Prete A; Cozza R; Bertulli R; Podda M; Ferrari S; Luksch R
Eur J Cancer; 2013 Nov; 49(17):3658-65. PubMed ID: 23890769
[TBL] [Abstract][Full Text] [Related]
12. A novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis.
Colleoni L; Galbardi B; Barzago C; Bonanno S; Franzi S; Frangiamore R; Camera G; Foti M; Biancolini D; Canioni E; Maggi L; Antozzi C; Mantegazza R; Bernasconi P; Kapetis D
Pharmacogenet Genomics; 2017 Feb; 27(2):51-56. PubMed ID: 27922550
[TBL] [Abstract][Full Text] [Related]
13. Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients.
Genvigir FDV; Nishikawa AM; Felipe CR; Tedesco-Silva H; Oliveira N; Salazar ABC; Medina-Pestana JO; Doi SQ; Hirata MH; Hirata RDC
Pharmacotherapy; 2017 May; 37(5):535-545. PubMed ID: 28316087
[TBL] [Abstract][Full Text] [Related]
14. Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.
Arshi A; Sharim J; Park DY; Park HY; Yazdanshenas H; Bernthal NM; Shamie AN
Spine J; 2017 May; 17(5):645-655. PubMed ID: 27856382
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma.
Hegyi M; Arany A; Semsei AF; Csordas K; Eipel O; Gezsi A; Kutszegi N; Csoka M; Muller J; Erdelyi DJ; Antal P; Szalai C; Kovacs GT
Oncotarget; 2017 Feb; 8(6):9388-9398. PubMed ID: 27566582
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study.
Kopp TI; Andersen V; Tjonneland A; Vogel U
Scand J Gastroenterol; 2015; 50(12):1469-81. PubMed ID: 26109419
[TBL] [Abstract][Full Text] [Related]
17. Long-term Outcomes and Complications in Pediatric Ewing Sarcoma.
Hamilton SN; Carlson R; Hasan H; Rassekh SR; Goddard K
Am J Clin Oncol; 2017 Aug; 40(4):423-428. PubMed ID: 25599318
[TBL] [Abstract][Full Text] [Related]
18. The contribution of CYP2C gene subfamily involved in epoxygenase pathway of arachidonic acids metabolism to hypertension susceptibility in Russian population.
Polonikov A; Bykanova M; Ponomarenko I; Sirotina S; Bocharova A; Vagaytseva K; Stepanov V; Churnosov M; Bushueva O; Solodilova M; Shvetsov Y; Ivanov V
Clin Exp Hypertens; 2017; 39(4):306-311. PubMed ID: 28513222
[TBL] [Abstract][Full Text] [Related]
19. Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
van Maldegem AM; Benson C; Rutkowski P; Blay JY; van den Berg H; Placzke J; Rasper M; Judson I; Juergens H; Dirksen U; Gelderblom H
Pediatr Blood Cancer; 2015 Jan; 62(1):40-4. PubMed ID: 25251256
[TBL] [Abstract][Full Text] [Related]
20. Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients.
Palmerini E; Jones RL; Setola E; Picci P; Marchesi E; Luksch R; Grignani G; Cesari M; Longhi A; Abate ME; Paioli A; Szucs Z; D'ambrosio L; Scotlandi K; Fagioli F; Asaftei S; Ferrari S
Acta Oncol; 2018 Jul; 57(7):958-964. PubMed ID: 29533113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
